Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Dec;13(12):1339-48.
doi: 10.1093/neuonc/nor133. Epub 2011 Sep 12.

Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance

Affiliations
Case Reports

Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance

Daniela Kuhnt et al. Neuro Oncol. 2011 Dec.

Erratum in

  • Neuro Oncol. 2014 Oct;16(10):1429

Abstract

Extent of resection (EOR) still remains controversial in therapy of glioblastoma multiforme (GBM). However, an increasing number of studies favor maximum EOR as being associated with longer patient survival. One hundred thirty-five GBM patients underwent tumor resection aided by 1.5T intraoperative MRI (iMRI) and integrated multimodal navigation. Tumor volume was quantified by manual segmentation. The influences of EOR, patient age, recurrent tumor, tumor localization, and gender on survival time were examined. Intraoperative MRI detected residual tumor volume in 88 patients. In 19 patients surgery was continued; further resection resulted in final gross total resection (GTR) for 9 patients (GTR increased from 47 [34.80%] to 56 [41.49%] patients). Tumor volumes were significantly reduced from 34.25 ± 23.68% (first iMRI) to 1.22 ± 16.24% (final iMRI). According to Kaplan-Meier estimates, median survival was 14 months (95% confidence interval [CI]: 11.7-16.2) for EOR ≥ 98% and 9 months (95% CI: 7.4-10.5) for EOR <98% (P< .0001); it was 9 months (95% CI: 7.3-10.7) for patients ≥ 65 years and 12 months (95% CI: 8.4-15.6) for patients <65 years (P < .05). Multivariate analysis showed a hazard ratio of 0.39 (95% CI: 0.24-0.63; P = .001) for EOR ≥ 98% and 0.61 (95% CI: 0.38-0.97; P < .05) for patient age <65 years. To our knowledge, this is the largest study including correlation of iMRI, tumor volumetry, and survival time. We demonstrate that navigation guidance and iMRI significantly contribute to optimal EOR with low postoperative morbidity, where EOR ≥ 98% and patient age <65 years are associated with significant survival advantages. Thus, maximum EOR should be the surgical goal in GBM surgery while preserving neurological function.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Workflow figure illustrating the surgical procedure in the setting of iMRI. (Gd: gadolinium).
Fig. 2.
Fig. 2.
Illustrative Case: MRI scans of a 60-year-old male patient with recurrent left parietal GBM during the surgical procedure. (A) Preoperative MRI, head already fixed, immediately before surgery (tumor volume: 57.3 mL). (B) First iMRI after estimated best possible tumor resection with a residual tumor mass of 2.32 mL. (C) Second iMRI after further tumor resection due to the first intraoperative scans, now showing gross total resection.
Fig. 3.
Fig. 3.
Kaplan–Meier estimates of survival in univariate analysis with respect to patient age (≥65 years/<65 years). Median survival: 9 months (95% CI: 7.3–10.7) for patients ≥65 years, 12 months (95% CI: 8.4–15.6) for patients <65 years (P < .04).
Fig. 4.
Fig. 4.
Kaplan–Meier estimates of survival in univariate analysis with respect to EOR (≥98%/<98%). Median survival: 14 months (95% CI: 11.7–16.2) for EOR ≥98%, 9 months (95% CI: 7.4–10.5) for EOR <98% (P < .001).
Fig. 5.
Fig. 5.
Cox proportional hazards model with respect to EOR (≥98%/<98%), (P < .0001).

References

    1. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61(3):215–225. discussion 226–219. - PubMed
    1. Kortmann RD, Jeremic B, Weller M, Plasswilm L, Bamberg M. Radiochemotherapy of malignant glioma in adults. Clinical experiences. Strahlenther Onkol. 2003;179(4):219–232. doi:10.1007/s00066-003-1027-y. - DOI - PubMed
    1. Keles GE, Chang EF, Lamborn KR, et al. Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma. J Neurosurg. 2006;105(1):34–40. doi:10.3171/jns.2006.105.1.34. - DOI - PubMed
    1. Leighton C, Fisher B, Bauman G, et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol. 1997;15(4):1294–1301. - PubMed
    1. Pope WB, Sayre J, Perlina A, Villablanca JP, Mischel PS, Cloughesy TF. MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol. 2005;26(10):2466–2474. - PMC - PubMed

Publication types

MeSH terms